Smead Capital Management disclosed 27 US equity positions worth $83.0m in its Q1 2009 13F filing. Its largest position is MSFT at 11.1% of the reported book, followed by Merck & Co Inc and WMT. Versus Q4 2008 it opened 3 new positions, added to 8, reduced 15 and exited 7.
$83.0m
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
27
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
11.1%
Largest position
The largest single position as a share of the reported equity book.
75.6%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
15
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
75
Quarters on file since Q4 2007
Quarters for which this manager's 13F holdings are on record.